Description

This technology uses nanotechnology and genome-related techniques (e.g., colloidal gold nanoparticles (AuNPs) immune assay) in the development of a rapid detection kit against bacterial pathogens in Tilapia (i.e., Aeromonas hydrophila and Enterococcus faecalis). This technology aims to contribute to the tilapia aquaculture industry by helping prevent fish mortality in the early stages, thus early detection of pathogens thereby giving farmers immediate precautionary and preventive actions to prevent disease outbreaks.